Search Results - Van Tornout, P.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    211 Patient satisfaction with day of admission surgery

    211 Patient satisfaction with day of admission surgery by Johnston, L, Van Tornout, P

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Use of 1-octadecanol as an internal standard for plasma lipid quantitation on chromarods

    Use of 1-octadecanol as an internal standard for plasma lipid quantitation on chromarods by Van Tornout, P., Vercaemst, R., Caster, H., Lievens, M.J., De Keersgieter, W., Soetewey, F., Rosseneu, M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing

    Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing by GONZALEZ-ZULUETA, M, BENDER, C. M, YANG, A. S, TUDUNG NGUYEN, BEART, R. W, VAN TORNOUT, J. M, JONES, P. A

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract A55: A first-in-human, phase I study of an oral hedgehog pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors

    Abstract A55: A first-in-human, phase I study of an oral hedgehog pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors by Siu, Lillian L., Papadopoulos, Kyriakos P., Alberts, Steven R., Taylor, Sara, Patnaik, Amita, Chen, Eric X., Tolcher, Anthony, Vakkalaguada, Blisse, Lang, Lixin, Ahlers, Christoph, Bennett, Kelly L., Van Tornout, Jan M.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Dasatinib (SPRYCEL®) in Children and Adolescents with Relapsed or Refractory Leukemia: Preliminary Results of the CA180018 Phase I/II Study from the ITCC Consortium

    Dasatinib (SPRYCEL®) in Children and Adolescents with Relapsed or Refractory Leukemia: Preliminary Results of the CA180018 Phase I/II Study from the ITCC Consortium by Zwaan, Christian M., Boer, M.L. den, Beverloo, H.B., van der Velden, V.H.J., Van Tornout, J.M.A., Derreumaux, D., Baruchel, A., Rizzari, C., Kearns, P., Pieters, R.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC

    Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC by J M Van Tornout, C H Spruck, 3rd, A Shibata, C Schmutte, M Gonzalez-Zulueta, P W Nichols, P T Chandrasoma, M C Yu, P A Jones

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: